Does Routine Anti-Osteoporosis Medication Lower the Risk of Fractures in Male Subjects? An Updated Systematic Review With Meta-Analysis of Clinical Trials

• Main Authors: Ling-Feng Zeng (Author), Bi-Qi Pan (Author), Gui-Hong Liang (Author), Ming-Hui Luo (Author), Ye Cao (Author), Da Guo (Author), Hong-Yun Chen (Author), Jian-Ke Pan (Author), He-Tao Huang (Author), Qiang Liu (Author), Zi-Tong Guan (Author), Yan-Hong Han (Author), Di Zhao (Author), Jin-Long Zhao (Author), Sen-Rong Hou (Author), Ming Wu (Author), Jiong-Tong Lin (Author), Jia-Hui Li (Author), Wei-Xiong Liang (Author), Ai-Hua Ou (Author), Qi Wang (Author), Wei-Yi Yang (Author), Jun Liu (Author)
• Format: Book
• Published: Frontiers Media S.A., 2019-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Several epidemiological articles have reported the correlations between anti-osteoporosis medication and the risks of fractures in male and female subjects, but the specific efficacy of anti-osteoporosis medication for male subjects remains largely unexplored.Objective: The aim of this s...